Search

everythinglearnresearchcommunity

for

Search:↓

A specific metabolite, not a receptor protein, triggers the production of certain kidney enzymes, but this process is disrupted in mice with a mutation causing testicular feminization.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Tabby mutations in mice affect hair follicle development and help study genetic mapping and certain medical conditions.

DHT affects testicular development and regulates spermatogenesis in some fish.

Androgens, like testosterone, are crucial for early testicular descent in rats.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The dog had a Sertoli cell tumor, which was successfully removed with surgery.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Finasteride negatively affects fish reproduction and gonadal development.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Anabolic-androgenic steroids are dangerous and educating people about their risks is essential.

A female dog with mixed male and female traits was treated successfully with surgery.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Treatment restored normal sexual characteristics and blood condition in a patient with testicular cancer.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Male infertility and genitourinary birth defects are often linked to genetic issues.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Current research explores hair growth drugs, while future research aims for personalized treatments.